Cargando…

The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast Cancer

OBJECTIVE: Tumor response to neoadjuvant chemotherapy (NAC) in breast cancer (BC) patients is a predictor for overall survival. The aim of our study was to determine a relationship between the neutrophil to lymphocyte ratio (NLR) prior to NAC, BC subtypes and the probability of a pathologic complete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivas, Mauricio, Acevedo, Francisco, Dominguez, Francisco, Galindo, Hector, Camus, Mauricio, Oddo, David, Villarroel, Alejandra, Razmilic, Dravna, Peña, Jose, Muñoz-Medel, Matias, Navarro, Maria Elena, Perez-Sepulveda, Alejandra, Medina, Lidia, Merino, Tomas, Briones, Juan, Kalergis, Alexis, Sanchez, Cesar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745205/ https://www.ncbi.nlm.nih.gov/pubmed/31350986 http://dx.doi.org/10.31557/APJCP.2019.20.7.2209

Ejemplares similares

Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
por: Oddó, David, et al.
Publicado: (2018)

Clinico-Pathologic Subtypes of Breast Cancer Primary Tumors Are Related to Prognosis after Recurrence
por: Sánchez, Cesar, et al.
Publicado: (2016)

Mammography correlates to better survival rates in breast cancer patients: a 20-year experience in a University health institution
por: Maiz, Cristóbal, et al.
Publicado: (2020)

Breast cancer and pregnancy: a comparative analysis of a Chilean cohort
por: Sánchez, César, et al.
Publicado: (2014)

Breast lesions with atypia in percutaneous biopsies, managed with surgery in the last 10 years
por: Carrillo, Mitzy, et al.
Publicado: (2019)

Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer
por: Canteros, Daniel, et al.
Publicado: (2022)

Breast papillary lesions: an analysis of 70 cases
por: Boin, Dahiana Pulgar, et al.
Publicado: (2014)

Risk factors for loco-regional recurrence in breast cancer patients: a retrospective study
por: Merino, Tomás, et al.
Publicado: (2018)

Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data
por: Walbaum, Benjamín, et al.
Publicado: (2021)

Peripheral Blood Classical Monocytes and Plasma Interleukin 10 Are Associated to Neoadjuvant Chemotherapy Response in Breast Cancer Patients
por: Valdés-Ferrada, Javier, et al.
Publicado: (2020)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer
por: Rojas, Luis, et al.
Publicado: (2020)

Oncological resection, myasthenia gravis and staging as prognostic factors in thymic tumours: a Chilean case series
por: Salas, Patricio, et al.
Publicado: (2021)

How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? Results from a Chilean survey
por: Acevedo, Francisco, et al.
Publicado: (2014)

Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective
por: Pinto, Mauricio P., et al.
Publicado: (2018)

Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients
por: Gejman, Roger, et al.
Publicado: (2019)

A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability
por: Pinto, Mauricio P., et al.
Publicado: (2020)

Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
por: García-Torralba, Esmeralda, et al.
Publicado: (2023)

Maturity-onset diabetes of the young type 3 and premature ovarian insufficiency: chance or causality: a case report and literature review
por: Alvarez, Mauricio, et al.
Publicado: (2022)

Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
por: Galindo, José, et al.
Publicado: (2013)

Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities
por: Calderillo, Germán, et al.
Publicado: (2020)

Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
por: Acevedo, Francisco, et al.
Publicado: (2022)

Effect of Atmospheric Corrosion on the Mechanical Properties of SAE 1020 Structural Steel
por: Martínez, Carola, et al.
Publicado: (2018)

Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer
por: Jaime Jans, B, et al.
Publicado: (2014)

Surgical treatment in oligometastatic breast cancer
por: Vargas, Catalina, et al.
Publicado: (2019)

Manejo del paciente diabético en odontología
por: Medel Ojeda, Alejandra Cecilia
Publicado: (2009)

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(−) Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2019)

Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer
por: Morales Murillo, Serafin, et al.
Publicado: (2021)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease
por: Knox, Aaron J, et al.
Publicado: (2014)

Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
por: Zhang, Zhuo, et al.
Publicado: (2021)

Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy
por: Yüksel, Cemil, et al.
Publicado: (2022)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

Respuesta viral sostenida en pacientes con hepatitis C y enfermedad renal crónica
por: Jasso-Baltazar, Erick Augusto, et al.
Publicado: (2022)

Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
por: Fernández Vallone, Valeria, et al.
Publicado: (2023)

ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer
por: Gong, Yajie, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
por: Dieci, Maria Vittoria, et al.
Publicado: (2022)

Mitochondrial DNA Variation in Peruvian Honey Bee (Apis mellifera L.) Populations Using the tRNA(leu)-cox2 Intergenic Region
por: Chávez-Galarza, Julio, et al.
Publicado: (2021)

Association between maternity leave policies and postpartum depression: a systematic review
por: Hidalgo-Padilla, Liliana, et al.
Publicado: (2023)

Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
por: Pfefferle, Adam D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fjkbtekvle81lb1407tf9fsg0v